Intelligence / Healthtech & medtech market map / Clinical and regulatory support services / Quality, compliance and lifecycle regulatory services / Medtech risk-management files and product-lifecycle regulatory documentation
Medtech risk-management files and product-lifecycle regulatory documentation
Creation and maintenance of ISO 14971 risk-management files, usability and biocompatibility risk inputs, technical-documentation and design-history support, design-change and obsolescence management, and regulatory due-diligence support for mergers, acquisitions and divestitures. Buyer is the device or diagnostic vendor; the job is to keep the regulatory file aligned with the product through its life; the trigger is a design change, an obsolescence event, a new market submission or a transaction.
- Level
- Niche
- Segmented by
- Customer type
- Buyers
- Medical-device and diagnostic manufacturers, including private-equity-owned and mid-market consolidators
- Buying centre
- Head of Regulatory Affairs (owner), R&D or Product Management Director, VP Operations, and corporate development for transaction work
- Design or component changes requiring updated risk analysis and filings
- Product obsolescence, discontinuation or supplier substitution
- Acquisition or divestiture requiring regulatory due diligence
- New market submissions requiring complete technical documentation
- Risk files that drift out of sync with design changes
- Technical documentation assembled from scratch for each submission
- Obsolescence and change-control work unplanned and costly
- Regulatory liabilities unidentified during transactions
How this was sized
$370M ($315M–$420M) · 2024 · Bottom-up
Bottom-up from the medtech device regulatory-affairs outsourcing pool of USD 2.1B in 2024 [2]. Assume risk-management files plus lifecycle technical documentation and regulatory due diligence are 15–20% of that pool: 2,100 x 0.15 = USD 315M; 2,100 x 0.20 = USD 420M; midpoint USD 370M. Forecast applies the published 6–7% CAGR [2]: 370 x 1.065^7 = USD 577M, rounded to USD 575M in 2031. Consistency check: the three medtech niches (quality systems 30–40%, digital health 10–15%, risk/lifecycle 15–20%) total 55–75% of the USD 2.1B device pool, leaving 25–45% for submissions, writing and registration. Share assumption unverified; Low confidence.
- Medtech Outsourcing and Software Market Size (2026)
askdona.com · 2026-10-31
Alongside it in Quality, compliance and lifecycle regulatory services
// Sell into Medtech risk-management files and product-lifecycle regulatory documentation